| Literature DB >> 29657030 |
Qiuying Chen1, Kathryne Kirk2, Yevgeniya I Shurubor2, Dazhi Zhao2, Andrea J Arreguin2, Ifrah Shahi2, Federica Valsecchi2, Guido Primiano3, Elizabeth L Calder4, Valerio Carelli5, Travis T Denton6, M Flint Beal2, Steven S Gross1, Giovanni Manfredi7, Marilena D'Aurelio8.
Abstract
Using molecular, biochemical, and untargeted stable isotope tracing approaches, we identify a previously unappreciated glutamine-derived α-ketoglutarate (αKG) energy-generating anaplerotic flux to be critical in mitochondrial DNA (mtDNA) mutant cells that harbor human disease-associated oxidative phosphorylation defects. Stimulating this flux with αKG supplementation enables the survival of diverse mtDNA mutant cells under otherwise lethal obligatory oxidative conditions. Strikingly, we demonstrate that when residual mitochondrial respiration in mtDNA mutant cells exceeds 45% of control levels, αKG oxidative flux prevails over reductive carboxylation. Furthermore, in a mouse model of mitochondrial myopathy, we show that increased oxidative αKG flux in muscle arises from enhanced alanine synthesis and release into blood, concomitant with accelerated amino acid catabolism from protein breakdown. Importantly, in this mouse model of mitochondriopathy, muscle amino acid imbalance is normalized by αKG supplementation. Taken together, our findings provide a rationale for αKG supplementation as a therapeutic strategy for mitochondrial myopathies.Entities:
Keywords: OXPHOS dysfunction; anaplerosis; glutamate; glutamine; metabolism; mitochondria; mitochondrial diseases; myopathy; skeletal muscle; α-ketoglutarate
Mesh:
Substances:
Year: 2018 PMID: 29657030 PMCID: PMC5932217 DOI: 10.1016/j.cmet.2018.03.002
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287